Attached files
| file | filename |
|---|---|
| S-1 - S-1 - Omthera Pharmaceuticals, Inc. | a2213342zs-1.htm |
| EX-4.3 - EX-4.3 - Omthera Pharmaceuticals, Inc. | a2213342zex-4_3.htm |
| EX-4.2 - EX-4.2 - Omthera Pharmaceuticals, Inc. | a2213342zex-4_2.htm |
| EX-10.4 - EX-10.4 - Omthera Pharmaceuticals, Inc. | a2213342zex-10_4.htm |
| EX-10.8 - EX-10.8 - Omthera Pharmaceuticals, Inc. | a2213342zex-10_8.htm |
| EX-10.9 - EX-10.9 - Omthera Pharmaceuticals, Inc. | a2213342zex-10_9.htm |
| EX-10.2 - EX-10.2 - Omthera Pharmaceuticals, Inc. | a2213342zex-10_2.htm |
| EX-10.15 - EX-10.15 - Omthera Pharmaceuticals, Inc. | a2213342zex-10_15.htm |
| EX-10.13 - EX-10.13 - Omthera Pharmaceuticals, Inc. | a2213342zex-10_13.htm |
| EX-10.10 - EX-10.10 - Omthera Pharmaceuticals, Inc. | a2213342zex-10_10.htm |
| EX-10.11 - EX-10.11 - Omthera Pharmaceuticals, Inc. | a2213342zex-10_11.htm |
| EX-10.12 - EX-10.12 - Omthera Pharmaceuticals, Inc. | a2213342zex-10_12.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated March 8, 2013, in the registration statement (Form S-1) and related Prospectus of Omthera Pharmaceuticals, Inc. dated March 8, 2013.
|
|
/s/ Ernst & Young LLP |
|
|
|
|
MetroPark, New Jersey |
|
|
March 8, 2013 |
|